All News #Library
Others
Zydus signs agreement with Synthon for 505(B)(2) oncology product
13 Feb 2025 //
EXPRESS PHARMA
Byondis Initiates Ph I Study of ADC [Vic-]Trastuzumab Duocarmazine + Niraparib
24 Aug 2020 //
PRESS RELEASE
Synthon Biopharmaceuticals Relaunches as Byondis
15 Apr 2020 //
BUSINESSWIRE
US FDA grants fast track status to Synthon’s trastuzumab duocarmazine
01 Feb 2018 //
PHARMABIZ
Regulatory approval in Europe granted for Synthon`s Glatiramer Acetate
05 Oct 2017 //
BIOSPECTRUM
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
12 Apr 2016 //
CPHI ONLINE

Market Place
Sourcing Support